Wacker Chemie AG (DE:WCH)
XETRA:WCH
Want to see DE:WCH full AI Analyst Report?
Top Page
Wacker Chemie AG
(XETRA:WCH)
Select Model
Select Model
Rating:53Neutral
Price Target:
€102.00
▲(9.56% Upside)
Action:Reiterated
Date:05/14/26
The score is held back primarily by weak financial performance (net losses, margin compression, and inconsistent free cash flow with higher leverage) and a stretched valuation (very high P/E). These negatives are partly offset by strong technical momentum, with the stock trading above major moving averages and a positive MACD.
Positive Factors
Diversified product portfolio across end markets
Wacker's broad, multi-segment product mix (silicones, polymers, polysilicon, biosolutions) serves construction, automotive, electronics, healthcare and renewable-energy chains. That diversification reduces single-market cyclicality and supports durable revenue streams as end-markets recover asynchronously.
Negative Factors
Revenue decline since 2023
Sustained revenue contraction since 2023 signals demand or pricing weakness across key product lines. Persistent top-line decline undermines operating leverage, constrains margin recovery, and makes earnings restoration harder without structural demand improvement or price/mix gains.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified product portfolio across end markets
Wacker's broad, multi-segment product mix (silicones, polymers, polysilicon, biosolutions) serves construction, automotive, electronics, healthcare and renewable-energy chains. That diversification reduces single-market cyclicality and supports durable revenue streams as end-markets recover asynchronously.
Read all positive factors
Wacker Chemie AG (WCH) vs. iShares MSCI Germany ETF (EWG)
Market Cap
€4.94B
Dividend Yield3.75%
Average Volume (3M)95.55K
Price to Earnings (P/E)―
Beta (1Y)1.37
Revenue GrowthN/A
EPS GrowthN/A
CountryDE
Employees16,655
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)-16.29
Shares Outstanding52,152,600
10 Day Avg. Volume102,598
30 Day Avg. Volume95,545
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.96
Price to Sales (P/S)0.63
P/FCF Ratio-1.23K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€90.51Price Target Upside-2.78% Downside
Rating ConsensusHold
Number of Analyst Covering12
EPS Forecast (FY)0.72
Revenue Forecast (FY)€5.72B
Wacker Chemie AG Business Overview & Revenue Model
Company Description
Wacker Chemie AG, together with its subsidiaries, provides chemical products worldwide. It operates through four divisions: Wacker Silicones, Wacker Polymers, Wacker Biosolutions, and Wacker Polysilicon. The Wacker Silicones division offers silane...
How the Company Makes Money
Wacker Chemie AG primarily makes money by manufacturing chemical and materials products and selling them to industrial customers under business-to-business supply contracts, with revenue recognized mainly from product sales (and, in some areas, se...
Wacker Chemie AG Earnings Call Summary
Earnings Call Date:Oct 30, 2025
(Q3-2025)
| % Change Since: |
Next Earnings Date:Jul 30, 2026
Earnings Call Sentiment Negative
The earnings call highlighted ongoing challenges such as decreased sales and EBITDA, negative net income, and a challenging market environment, particularly in Europe. Despite these issues, there are strategic efforts to improve cash flow and reduce costs, with strong performance in the semiconductor polysilicon segment. However, the overall sentiment is affected by the revised downward guidance and persistent market pressures.Positive Updates
Improved Net Cash Flow
Despite lower EBITDA, net cash flow improved to EUR 19 million, supported by targeted actions to reduce working capital.
Negative Updates
Decreased Sales and EBITDA
Sales in Q3 were EUR 1.34 billion, down 6% year-over-year. EBITDA declined to EUR 112 million from EUR 145 million a year ago, primarily due to lower pricing, foreign exchange, and volume mix.
Read all updates
Q3-2025 Updates
Positive
Negative
Improved Net Cash Flow
Despite lower EBITDA, net cash flow improved to EUR 19 million, supported by targeted actions to reduce working capital.
Read all positive updates
Company Guidance
During the Wacker Chemie AG Q3 2025 conference call, the company provided updated guidance amid challenging market conditions. The company reported Q3 sales of EUR 1.34 billion and an EBITDA of EUR 112 million, with a combined EBITDA from its four operating segments totaling EUR 159 million. This represented an 18% decline compared to the previous year and a 13% sequential decrease. Despite a lower EBITDA, net cash flow improved to EUR 19 million, supported by efforts to reduce working capital. The company revised its full-year sales forecast to the lower end of the EUR 5.5 billion to EUR 5.9 billion range and anticipates EBITDA in the lower half of the EUR 500 million to EUR 700 million range. Net cash flow is expected to be negative but significantly better than the prior year. Wacker Chemie plans to implement cost-saving measures targeting fixed production costs in early 2026 to enhance competitiveness and profitability amidst ongoing macroeconomic and competitive pressures.Wacker Chemie AG Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
56
Neutral
Cash Flow
48
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.41B | 5.49B | 5.72B | 6.40B | 8.21B | 6.21B |
| Gross Profit | 685.20M | 657.30M | 986.70M | 1.08B | 2.16B | 1.67B |
| EBITDA | 450.30M | 396.70M | 807.40M | 878.30M | 1.85B | 1.46B |
| Net Income | -797.90M | -821.10M | 241.00M | 313.60M | 1.25B | 806.90M |
Balance Sheet | ||||||
| Total Assets | 8.50B | 8.79B | 9.41B | 8.85B | 9.40B | 8.13B |
| Cash, Cash Equivalents and Short-Term Investments | 1.51B | 1.48B | 1.22B | 1.39B | 1.78B | 1.67B |
| Total Debt | 0.00 | 2.37B | 1.95B | 1.51B | 1.34B | 1.25B |
| Total Liabilities | 4.68B | 5.04B | 4.57B | 4.27B | 4.37B | 5.03B |
| Stockholders Equity | 3.65B | 3.60B | 4.67B | 4.42B | 4.86B | 3.02B |
Cash Flow | ||||||
| Free Cash Flow | 35.20M | -2.80M | -341.20M | 296.70M | 564.30M | 743.10M |
| Operating Cash Flow | 588.40M | 550.40M | 310.40M | 936.30M | 1.13B | 1.06B |
| Investing Cash Flow | -900.80M | -725.20M | -435.30M | -107.60M | -701.40M | -639.70M |
| Financing Cash Flow | 415.70M | 271.90M | 145.90M | -688.10M | -458.50M | -153.90M |
Wacker Chemie AG Technical Analysis
Positive
93.10
Price Trends
91.25
Positive
82.91
Positive
74.70
Positive
Market Momentum
2.04
Positive
56.12
Neutral
48.78
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:WCH, the sentiment is Positive. The current price of 93.1 is below the 20-day moving average (MA) of 97.78, above the 50-day MA of 91.25, and above the 200-day MA of 74.70, indicating a bullish trend. The MACD of 2.04 indicates Positive momentum. The RSI at 56.12 is Neutral, neither overbought nor oversold. The STOCH value of 48.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:WCH.
Wacker Chemie AG Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | €1.92B | 28.53 | 27.13% | 1.24% | ― | ― | |
64 Neutral | €7.93B | 49.89 | 1.89% | 8.92% | -9.37% | -47.49% | |
63 Neutral | €8.06B | 35.77 | 5.27% | 4.30% | -9.48% | -56.88% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
53 Neutral | €4.94B | -9.07 | -20.12% | 3.75% | ― | ― | |
49 Neutral | €1.41B | -2.16 | -17.77% | 0.59% | -14.31% | -386.04% | |
45 Neutral | €12.42B | -17.74 | -10.04% | ― | -8.72% | -140.66% |
* Basic Materials Sector Average
DE:WCH
Wacker Chemie AG
99.30
36.75
58.75%
DE:BNR
Brenntag AG
56.54
-1.17
-2.03%
DE:1COV
Covestro
59.80
-0.30
-0.50%
DE:EVK
Evonik
16.81
-2.25
-11.80%
DE:LXS
LANXESS
16.50
-10.50
-38.90%
DE:ACT
AlzChem Group AG
188.30
64.90
52.60%
Wacker Chemie AG Corporate Events
Regulatory Filings and Compliance
Silchester Stake in Wacker Chemie Slips Just Below 3% Threshold
Neutral
Apr 29, 2026
Wacker Chemie AG has disclosed a change in significant shareholding under German securities law, following a notification from Silchester International Investors LLP. The investment firm’s voting rights in Wacker Chemie have slipped just bel...
Business Operations and StrategyFinancial Disclosures
Wacker Chemie Lifts Q1 EBITDA Above Forecasts, Keeps Full-Year Outlook
Positive
Apr 17, 2026
Wacker Chemie AG reported that preliminary first-quarter 2026 EBITDA is expected to reach about €173 million on sales of roughly €1.41 billion, beating both its own earlier guidance and average market forecasts. The outperformance is m...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.